Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Mandatory Provider Training For Opioids Embraced By PhRMA

Executive Summary

Trade association members also commit tens of millions of dollars to set up addiction prevention programs and create new health care tools.


Related Content

Opioid REMS Increases Nearly Six-Fold As US FDA Adds Immediate-Release Products
Gottlieb's Priority For Proposed Opioid Money Is Mail Facilities
US FDA Chief Gottlieb Envisions Tiered Mandates For Opioid Training System
Opioid Packaging Standards Could Emerge From Dosage Guidelines in Labeling
Declaring Opioid Emergency, Trump Touts FDA Actions, NIH-Industry Partnerships
Opioid Abuse: The Limits Of Industry’s Response
FDA's Opioid Programs: After Training, What's The Next Step?





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts